Article
Immune alterations in untreated and treated multiple myeloma.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners - 1 Jun 2012
Dasanu Constantin A
Abstract excerpt
The incidence of second malignancies was shown to be increased in patients with multiple myeloma. Although a shared genetic predisposition or common environmental carcinogens may account for the occurrence of both myeloma and additional cancers, multiple immune defects encountered in myeloma might play an important role in this regard. This review explores the impairments in both cellular and humoral mediated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
